Response to Suissa and Azoulay. The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care 2014;37:1360-1366.
作者信息
Bordeleau Louise, Gerstein Hertzel C
机构信息
Department of Oncology, Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, Ontario, Canada
Department of Medicine, Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, Ontario, Canada.
出版信息
Diabetes Care. 2014 Oct;37(10):e217. doi: 10.2337/dc14-1220.
PMID:25249679
Abstract
摘要
相似文献
1
Response to Suissa and Azoulay. The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care 2014;37:1360-1366.对苏伊萨和阿祖莱的回应。甘精胰岛素和/或n-3脂肪酸与血糖异常患者新发癌症的关联。《糖尿病护理》2014年；37:1360 - 1366。
Diabetes Care. 2014 Oct;37(10):e217. doi: 10.2337/dc14-1220.
2
Comment on Bordeleau et al. The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care 2014;37:1360-1366.对博尔德洛等人的评论。甘精胰岛素和/或n-3脂肪酸与血糖异常患者新发癌症的关联。《糖尿病护理》2014年；37:1360 - 1366。
Diabetes Care. 2014 Oct;37(10):e216. doi: 10.2337/dc14-1075.
3
Comment on Bordeleau et al. The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care 2014;37:1360-1366.对博尔德洛等人的评论。甘精胰岛素和/或n-3脂肪酸与血糖异常患者新发癌症的关联。《糖尿病护理》2014年；37:1360 - 1366。
Diabetes Care. 2014 Oct;37(10):e221-2. doi: 10.2337/dc14-1380.
4
Response to Zanders et al. The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia. Diabetes Care 2014;37:1360-1366.对赞德斯等人的回应。甘精胰岛素和/或n-3脂肪酸与血糖异常患者新发癌症的关联。《糖尿病护理》2014年；37:1360 - 1366。
Diabetes Care. 2014 Oct;37(10):e223. doi: 10.2337/dc14-1567.
5
The association of basal insulin glargine and/or n-3 fatty acids with incident cancers in patients with dysglycemia.基础胰岛素甘精和/或 n-3 脂肪酸与糖代谢异常患者新发癌症的关联。
Diabetes Care. 2014;37(5):1360-6. doi: 10.2337/dc13-1468. Epub 2014 Feb 26.
6
Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial.甘精胰岛素和欧米伽-3 脂肪酸对糖代谢异常患者认知能力下降和可能的认知障碍的影响：ORIGIN 试验的子研究。
Lancet Diabetes Endocrinol. 2014 Jul;2(7):562-72. doi: 10.1016/S2213-8587(14)70062-2. Epub 2014 Jun 2.
7
n-3 fatty acids and cardiovascular outcomes in dysglycemia.n-3脂肪酸与血糖异常中的心血管结局
N Engl J Med. 2012 Nov 1;367(18):1760; author reply 1761. doi: 10.1056/NEJMc1210552.
8
n-3 fatty acids and cardiovascular outcomes in dysglycemia.n-3脂肪酸与血糖异常患者的心血管结局
N Engl J Med. 2012 Nov 1;367(18):1760-1; author reply 1761. doi: 10.1056/NEJMc1210552.
9
Insulin degludec: a new insulin for today?德谷胰岛素：当下的新型胰岛素？
Diabet Med. 2013 Nov;30(11):1267. doi: 10.1111/dme.12319.
10
[Early insulin treatment in type 2 diabetes--no].[2型糖尿病的早期胰岛素治疗——否定]
Dtsch Med Wochenschr. 2013 May;138(18):957. doi: 10.1055/s-0032-1332974. Epub 2013 Apr 23.
Zotero 插件